Trial
NCT04231526
Pembrolizumab in Early Stage Colon Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
Merck Sharp & Dohme LLC
Condition
Colon Cancer
Intervention
Pembrolizumab
Why stopped
unable to accrue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-31